DrakeStar：2024年上半年欧洲和美国远程医疗报告（英文版）

Telemedicine M&A activity increased during H1 2024, with 28 deals compared to 22 in H1 2023 and 20 in H2 2023. In H1 2024, the US represented a larger proportion of telemedicine M&A activity, completing 20 deals (71% of total deals) compared to 13 deals (60% of total deals) in H1 2023 Main rationales for M&A transactions were integrations from external players such as insurance and healthcare companies and product offering reinforcements from Telemedicine players